Statements: GSK Advance Company Ltd

Canonical ID: NK-QfFkwcpTeaFHBpwC4e2GeA · Entity type: Company (reference)

This table shows statement-based, sourced records from our database. For more context, learn about how OpenSanctions stores information.

Property	Value	Lang	Source dataset	Source ID	First seen
`LegalEntity:address`	AHMED KHAIR STREET, 11111 KHARTOUM, SDN	eng	us_sam_exclusions	`usgsa-s4mrvqghp`	2025-02-15
`LegalEntity:address`	AHMED KHAIR STREET, 11111 KHARTOUM, SDN	eng	us_sam_exclusions	`usgsa-s4mrvqqh0`	2025-02-16
`LegalEntity:address`	AHMED KHAIR STREET, 11111 KHARTOUM, SDN	eng	us_sam_exclusions	`usgsa-s4mrvqp60`	2025-02-16
`LegalEntity:address`	AHMED KHAIR STREET, 11111 KHARTOUM, SDN	eng	us_sam_exclusions	`usgsa-s4mrvqhwx`	2025-02-15
`LegalEntity:country`	sd	eng	us_sam_exclusions	`usgsa-s4mrvqqh0`	2025-02-16
`LegalEntity:country`	sd	eng	us_sam_exclusions	`usgsa-s4mrvqp60`	2025-02-16
`LegalEntity:country`	sd	eng	us_sam_exclusions	`usgsa-s4mrvqghp`	2025-02-15
`LegalEntity:country`	sd	eng	us_sam_exclusions	`usgsa-s4mrvqhwx`	2025-02-15
`LegalEntity:createdAt`	2025-02-13	eng	us_sam_exclusions	`usgsa-s4mrvqghp`	2025-02-15
`LegalEntity:createdAt`	2025-02-13	eng	us_sam_exclusions	`usgsa-s4mrvqhwx`	2025-02-15
`LegalEntity:createdAt`	2025-02-14	eng	us_sam_exclusions	`usgsa-s4mrvqp60`	2025-02-16
`LegalEntity:createdAt`	2025-02-14	eng	us_sam_exclusions	`usgsa-s4mrvqqh0`	2025-02-16
`LegalEntity:id`	f4daa6aac0861970703bbdb25a2a7a11d7a62371	eng	us_sam_exclusions	`usgsa-s4mrvqghp`	2025-02-23
`LegalEntity:id`	cf431519c1ce66d7313b16e317d415a71b8befcf	eng	us_sam_exclusions	`usgsa-s4mrvqqh0`	2025-07-23
`LegalEntity:id`	40be8bfdb51199a1dc672c07b6f32c54306ee96c	eng	us_sam_exclusions	`usgsa-s4mrvqhwx`	2025-07-23
`LegalEntity:id`	e1a0390be4a827ddbd0da935ee64a98168d73b4c	eng	us_sam_exclusions	`usgsa-s4mrvqp60`	2025-07-23
`LegalEntity:name`	GSK ADVANCE COMPANY LTD	eng	us_sam_exclusions	`usgsa-s4mrvqhwx`	2025-02-15
`LegalEntity:name`	GSK FOR ADVANCED BUSINESS CO. LTD	eng	us_sam_exclusions	`usgsa-s4mrvqp60`	2025-02-16
`LegalEntity:name`	GSK ADVANCE COMPANY LTD	eng	us_sam_exclusions	`usgsa-s4mrvqghp`	2025-02-15
`LegalEntity:name`	GSK FOR ADVANCED BUSINESS CO. LTD	eng	us_sam_exclusions	`usgsa-s4mrvqqh0`	2025-02-16
`LegalEntity:notes`	(also GSK ADVANCE COMPANY LTD)	eng	us_sam_exclusions	`usgsa-s4mrvqp60`	2025-07-23
`LegalEntity:notes`	(also GSK ADVANCE COMPANY LTD)	eng	us_sam_exclusions	`usgsa-s4mrvqqh0`	2025-07-23
`LegalEntity:notes`	(also GSK FOR ADVANCED BUSINESS CO. LTD, GSK FOR ADVANCED BUSINESS CO. LTD)	eng	us_sam_exclusions	`usgsa-s4mrvqhwx`	2025-07-23
`LegalEntity:topics`	sanction	eng	us_sam_exclusions	`usgsa-s4mrvqqh0`	2025-02-16
`LegalEntity:topics`	sanction	eng	us_sam_exclusions	`usgsa-s4mrvqp60`	2025-02-16
`LegalEntity:topics`	sanction	eng	us_sam_exclusions	`usgsa-s4mrvqghp`	2025-02-15
`LegalEntity:topics`	sanction	eng	us_sam_exclusions	`usgsa-s4mrvqhwx`	2025-02-15
`LegalEntity:uniqueEntityId`	LDPRQC89UPV6	eng	us_sam_exclusions	`usgsa-s4mrvqqh0`	2025-02-16
`LegalEntity:uniqueEntityId`	P79LESZJLSN7	eng	us_sam_exclusions	`usgsa-s4mrvqhwx`	2025-02-15
`LegalEntity:uniqueEntityId`	LDPRQC89UPV6	eng	us_sam_exclusions	`usgsa-s4mrvqp60`	2025-02-16
`LegalEntity:uniqueEntityId`	P79LESZJLSN7	eng	us_sam_exclusions	`usgsa-s4mrvqghp`	2025-02-15

Previous
1 - 31 of 31
Next